# Assess Intraoperative Pain for Restorative Treatment of Maxillary 1st Permanent Molars Using Artinibsa Versus Artpharma in Children During Infiltration Technique

> **NCT04303234** · NA · UNKNOWN · sponsor: **Cairo University** · enrollment: 46 (estimated)

## Conditions studied

- Pain

## Interventions

- **OTHER:** Artinibsa
- **OTHER:** Artpharma

## Key facts

- **NCT ID:** NCT04303234
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-01
- **Primary completion:** 2021-04-01
- **Final completion:** 2021-10-01
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2020-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04303234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04303234, "Assess Intraoperative Pain for Restorative Treatment of Maxillary 1st Permanent Molars Using Artinibsa Versus Artpharma in Children During Infiltration Technique". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT04303234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*